Hence, a strategy for the prevention and treatment of lung cancer could involve the regulation of inflammatory molecules, including pro-inflammatory cytokines, and inflammatory enzymes, such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthetase (iNOS) [17,18]. The gene discussed is PTGS2; the disease is lung cancer.